Monique G.C.T. van Oijen

Author

National Institute for Public Health and the Environment

Also Known As

M. G. C. T. van Oijen, M.G.C.T. van Oijen, Monique G. C. T. Van Oijen, Monique G. C. T. van Oijen, Monique G.C.T. van Oijen

Publications

672

Citations

H-Index

Concepts

All Affiliations

National Institute for Public Health and the Environment Intravacc (Netherlands)Jordan Hospital World Health Organization Centers for Disease Control and Prevention

About

Monique G.C.T. van Oijen is an author at National Institute for Public Health and the Environment specializing in medicine, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	506
2	Cell Biology	2	2	174
3	Health Sciences	1	1	40
4	Allergy	1	1	30
5	Cellular Physiology	1	1	144

Monique G.C.T. van Oijen

Publications

653

Citations

H-Index

Page 1

	Year	Citations
Positivity of the Proliferation Marker Ki-67 in Noncycling Cells Monique G.C.T. van Oijen, René H. Medema, Pieter J. Slootweg, American Journal of Clinical Pathology Ki-67 AntigenImmunologyPathologyCell ProliferationCell Cycle	1998	144
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV Wilfried A.M. Bakker, Yvonne E. Thomassen, Aart G. van’t Oever, Vaccine VaccinationCell-based Vaccine ProductionPolio Vaccine DevelopmentVaccine DevelopmentImmunology	2011	92
The origins of multiple squamous cell carcinomas in the aerodigestive tract Monique G.C.T. van Oijen, Fredriek G. J. Leppers vd Straat, Marcel G.J. Tilanus, Cancer	2000	89
In situ detection of virus- and tumor-specific T-cell immunity John B.A.G. Haanen, Monique G.C.T. van Oijen, Felicia H. Tirion, Nature Medicine Cancer ImmunosurveillanceImmunologyTumor ImmunityT Cell ImmunityCellular Immune Response	2000	80
Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression Monique G.C.T. van Oijen, Marcel G.J. Tilanus, René H. Medema, Journal of Oral Pathology and Medicine	1998	58
Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals Yvonne E. Thomassen, Aart G. van ’t Oever, Monique G.C.T. van Oijen, PLoS ONE ImmunologyWorldwide EffortsVaccine TargetInfection ControlPolio	2013	53
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants Pauline Verdijk, Nynke Y. Rots, Monique G.C.T. van Oijen, Vaccine Maternal ImmunizationImmunohematologyAluminum HydroxidePathogenesisImmunology	2014	40
p53 overexpression in oral mucosa in relation to smoking Monique G.C.T. van Oijen, Johanna G. van de Craats, Pieter J. Slootweg The Journal of Pathology Tumour-suppressor Protein P53Tobacco ControlTumor BiologyP53-positive ClustersOral Mucosa	1999	34
Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults Pauline Verdijk, Nynke Y. Rots, Monique G.C.T. van Oijen, Vaccine VaccinationVaccine SafetySabin StrainsVaccine DevelopmentAluminum Hydroxide	2013	33
Increased number of proliferating cells in oral epithelium from smokers and ex-smokers Monique G.C.T. van Oijen, M.M.A. Gilsing, Gert Rijksen, Oral Oncology Tobacco ControlAllergyOral CavityNicotineOral Biology	1998	30

Page 1